<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/global/feed/rss.xslt" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podaccess="https://access.acast.com/schema/1.0/" xmlns:acast="https://schema.acast.com/1.0/">
    <channel>
		<ttl>60</ttl>
		<generator>acast.com</generator>
		<title>Photobiology? Eh Aye!</title>
		<link>https://feeds.acast.com/public/shows/photobiology-eh-aye</link>
		<atom:link href="https://feeds.acast.com/public/shows/679f7f23e7c33ddc007c7792" rel="self" type="application/rss+xml"/>
		<language>en</language>
		<copyright>Stephanie Logan</copyright>
		<itunes:keywords>artificial intelligence,photobiology,light sensitivity,phototherapy,photodynamic thearpy,laser therapy</itunes:keywords>
		<itunes:author>Stephanie Logan</itunes:author>
		<itunes:subtitle/>
		<itunes:summary><![CDATA[A brand-new podcast using AI (Eh Aye) to discuss the latest research from the Photobiology Unit at Ninewells Hospital in Dundee.health<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		<description><![CDATA[A brand-new podcast using AI (Eh Aye) to discuss the latest research from the Photobiology Unit at Ninewells Hospital in Dundee.health<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
		<itunes:explicit>false</itunes:explicit>
		<itunes:owner>
			<itunes:name>Stephanie Logan</itunes:name>
			<itunes:email>info+679f7f23e7c33ddc007c7792@mg-eu.acast.com</itunes:email>
		</itunes:owner>
		<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
		<acast:showUrl>photobiology-eh-aye</acast:showUrl>
		<acast:signature key="EXAMPLE" algorithm="aes-256-cbc"><![CDATA[wbG1Z7+6h9QOi+CR1Dv0uQ==]]></acast:signature>
		<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmTHg2/BXqPr07kkpFZ5JfhvEZqggcpunI6E1w81XpUaBscFc3skEQ0jWG4GCmQYJ66w6pH6P/aGd3DnpJN6h/CD4icd8kZVl4HZn12KicA2k]]></acast:settings>
        <acast:network id="65118b8302b32f001106216e" slug="stephanie-logan-"><![CDATA[Stephanie Logan ]]></acast:network>
		<itunes:type>episodic</itunes:type>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<image>
				<url>https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg</url>
				<link>https://feeds.acast.com/public/shows/photobiology-eh-aye</link>
				<title>Photobiology? Eh Aye!</title>
			</image>
		<item>
			<title>Enhancing Patient-Centred Care for Photosensitivity Disorders</title>
			<itunes:title>Enhancing Patient-Centred Care for Photosensitivity Disorders</itunes:title>
			<pubDate>Fri, 14 Nov 2025 11:31:39 GMT</pubDate>
			<itunes:duration>13:09</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/6853e10d412e0f0fbf3159af/media.mp3" length="25421314" type="audio/mpeg"/>
			<guid isPermaLink="false">6853e10d412e0f0fbf3159af</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/photobiology-eh-aye/episodes/6853e10d412e0f0fbf3159af</link>
			<acast:episodeId>6853e10d412e0f0fbf3159af</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ3evibvwWlhg4UlPa0egqEG/e+7wBr/O6SZQglpr5muIx9oetassaE6TrqN6HzWx4TJMWs1mRTO5n8VyhyYPE//]]></acast:settings>
			<itunes:subtitle>An AI generated audio overview of publication Realising Realistic Medicine by enhancing Patient-Centred Care: The Scottish Photobiology Service’s Approach to Engaging Patients with Photosensitivity Disorders</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[This AI generated overview of academic paper,&nbsp;"Realising Realistic Medicine by enhancing Patient-Centred Care: The Scottish Photobiology Service’s Approach to Engaging Patients with Photosensitivity Disorders,"&nbsp;presents a detailed account of the Scottish Photobiology Service's (SPS) efforts to improve patient care for individuals with photosensitivity conditions. The document, published in the&nbsp;Journal of the Royal College of Physicians of Edinburgh, outlines the&nbsp;development, implementation, and outcomes&nbsp;of a patient engagement programme initiated in 2019. This programme, designed to align with Scotland's "Realistic Medicine" concept, focuses on placing patients at the centre of their care through&nbsp;collaborative workshops, virtual meetings, and educational resources&nbsp;like podcasts and information cards for various stakeholders. The paper highlights key successes, including&nbsp;addressing referral delays, fostering peer support through groups like PALS, and enhancing patient satisfaction, demonstrating how patient involvement can significantly&nbsp;improve healthcare delivery.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[This AI generated overview of academic paper,&nbsp;"Realising Realistic Medicine by enhancing Patient-Centred Care: The Scottish Photobiology Service’s Approach to Engaging Patients with Photosensitivity Disorders,"&nbsp;presents a detailed account of the Scottish Photobiology Service's (SPS) efforts to improve patient care for individuals with photosensitivity conditions. The document, published in the&nbsp;Journal of the Royal College of Physicians of Edinburgh, outlines the&nbsp;development, implementation, and outcomes&nbsp;of a patient engagement programme initiated in 2019. This programme, designed to align with Scotland's "Realistic Medicine" concept, focuses on placing patients at the centre of their care through&nbsp;collaborative workshops, virtual meetings, and educational resources&nbsp;like podcasts and information cards for various stakeholders. The paper highlights key successes, including&nbsp;addressing referral delays, fostering peer support through groups like PALS, and enhancing patient satisfaction, demonstrating how patient involvement can significantly&nbsp;improve healthcare delivery.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Sunscreen and Photoprotection Habits for Photosensitive Patients</title>
			<itunes:title>Sunscreen and Photoprotection Habits for Photosensitive Patients</itunes:title>
			<pubDate>Fri, 14 Nov 2025 11:29:16 GMT</pubDate>
			<itunes:duration>14:42</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/685ecaea47311de1b66a44da/media.mp3" length="42343724" type="audio/mpeg"/>
			<guid isPermaLink="false">685ecaea47311de1b66a44da</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://doi.org/10.1111/phpp.70034</link>
			<acast:episodeId>685ecaea47311de1b66a44da</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ3CuEVgQXWK5RWAOr7OcKDxh6F/ScIyHYjXVsw0jhnxh4/QrP6XM/J3P9cvbILyM84VhYzGlDT1HxMqoL3c9X82]]></acast:settings>
			<itunes:subtitle>An AI generated overview of Sunscreen and Photoprotection Habits for Patients With Porphyria and Non-Porphyric Photosensitivity Conditions</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[<p>This is an AI generated summary of the publication <strong>Sunscreen and Photoprotection Habits for Patients With Porphyria and Non-Porphyric Photosensitivity Conditions</strong> from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This research&nbsp;explores the sunscreen and photoprotection habits&nbsp;of individuals with photosensitivity conditions, specifically comparing those with porphyria to those with non-porphyric photosensitivity. The&nbsp;study highlights the challenges patients face in selecting effective sunscreens, given the wide variety of products and the limited guidance on their efficacy, especially concerning protection against visible light. Findings indicate that&nbsp;protection efficacy is the primary factor&nbsp;influencing sunscreen choice, particularly for porphyria patients, who often require sunscreens that protect against visible light. The authors reveal that&nbsp;many patients struggle with sunscreen selection, reporting issues with product suitability and expressing a need for&nbsp;improved guidance and accessibility&nbsp;to tailored sunscreens. This study&nbsp;underscores that sunscreens are a crucial supplement&nbsp;to broader photoprotection strategies, but they are not a standalone solution for photosensitive individuals.</p><br><p>Publication: https://doi.org/10.1111/phpp.70034</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is an AI generated summary of the publication <strong>Sunscreen and Photoprotection Habits for Patients With Porphyria and Non-Porphyric Photosensitivity Conditions</strong> from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This research&nbsp;explores the sunscreen and photoprotection habits&nbsp;of individuals with photosensitivity conditions, specifically comparing those with porphyria to those with non-porphyric photosensitivity. The&nbsp;study highlights the challenges patients face in selecting effective sunscreens, given the wide variety of products and the limited guidance on their efficacy, especially concerning protection against visible light. Findings indicate that&nbsp;protection efficacy is the primary factor&nbsp;influencing sunscreen choice, particularly for porphyria patients, who often require sunscreens that protect against visible light. The authors reveal that&nbsp;many patients struggle with sunscreen selection, reporting issues with product suitability and expressing a need for&nbsp;improved guidance and accessibility&nbsp;to tailored sunscreens. This study&nbsp;underscores that sunscreens are a crucial supplement&nbsp;to broader photoprotection strategies, but they are not a standalone solution for photosensitive individuals.</p><br><p>Publication: https://doi.org/10.1111/phpp.70034</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Far-UVC Safety for Photosensitivity Disorders</title>
			<itunes:title>Far-UVC Safety for Photosensitivity Disorders</itunes:title>
			<pubDate>Wed, 18 Jun 2025 07:49:49 GMT</pubDate>
			<itunes:duration>10:54</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/68526f9e259ce49e3e50e72b/media.mp3" length="31393964" type="audio/mpeg"/>
			<guid isPermaLink="false">68526f9e259ce49e3e50e72b</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://doi.org/10.1093/bjd/ljaf193</link>
			<acast:episodeId>68526f9e259ce49e3e50e72b</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ1hgJdLOLw/+f1k5orHsIDQQta+ItNY7G+m+ydsagMdVmqOAlnFsQs4UdAjNBsFVMOAVjRo0IVjSMNssUpBAdZH]]></acast:settings>
			<itunes:subtitle>An AI generated overview of Far-UVC Exposure in Patients with Photosensitivity Disorders</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[<p>This is an AI generated summary of the publication <strong>Far-UVC Exposure in Patients with Photosensitivity Disorders</strong> from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This academic article, published in the <em>British Journal of Dermatology, </em>investigates the&nbsp;safety of Far-UVC light (200-230 nm)&nbsp;for individuals with&nbsp;photosensitivity disorders, a group often experiencing adverse skin reactions to various light wavelengths. Far-UVC is known for its&nbsp;germicidal properties&nbsp;and is considered a promising tool for reducing infectious disease transmission. The study, conducted at a photodiagnostic unit in Scotland, involved&nbsp;phototesting 83 patients, including those with diagnosed photosensitivity, using a filtered krypton chloride lamp that emits Far-UVC at 222 nm. Importantly,&nbsp;no visible skin changes&nbsp;were observed in any participant, even at the maximum exposure aligned with&nbsp;international safety guidelines. These findings suggest that Far-UVC, when properly filtered and within recommended exposure limits, is&nbsp;unlikely to harm photosensitive skin, supporting its broader use as a disinfection method in public spaces.</p><br><p>Publication: https://doi.org/10.1093/bjd/ljaf193</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is an AI generated summary of the publication <strong>Far-UVC Exposure in Patients with Photosensitivity Disorders</strong> from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This academic article, published in the <em>British Journal of Dermatology, </em>investigates the&nbsp;safety of Far-UVC light (200-230 nm)&nbsp;for individuals with&nbsp;photosensitivity disorders, a group often experiencing adverse skin reactions to various light wavelengths. Far-UVC is known for its&nbsp;germicidal properties&nbsp;and is considered a promising tool for reducing infectious disease transmission. The study, conducted at a photodiagnostic unit in Scotland, involved&nbsp;phototesting 83 patients, including those with diagnosed photosensitivity, using a filtered krypton chloride lamp that emits Far-UVC at 222 nm. Importantly,&nbsp;no visible skin changes&nbsp;were observed in any participant, even at the maximum exposure aligned with&nbsp;international safety guidelines. These findings suggest that Far-UVC, when properly filtered and within recommended exposure limits, is&nbsp;unlikely to harm photosensitive skin, supporting its broader use as a disinfection method in public spaces.</p><br><p>Publication: https://doi.org/10.1093/bjd/ljaf193</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Eyewear Protection in PUVA Photochemotherapy</title>
			<itunes:title>Eyewear Protection in PUVA Photochemotherapy</itunes:title>
			<pubDate>Mon, 19 May 2025 17:24:55 GMT</pubDate>
			<itunes:duration>10:31</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/682b69683e2c04fd7a65be90/media.mp3" length="30313004" type="audio/mpeg"/>
			<guid isPermaLink="false">682b69683e2c04fd7a65be90</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://doi.org/10.1007/s43630-025-00714-x</link>
			<acast:episodeId>682b69683e2c04fd7a65be90</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ1RG71rJSn5QxhpSZO6TGCiWHnMbJGs1rZ/X+500cTzZUySsp1RYhn/6S5nyYml99PZvkc+AFD2sbnbkTrOuTH/]]></acast:settings>
			<itunes:subtitle>An AI generated overview of Eyewear Protection in PUVA Photochemotherapy</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[<p>This is an AI generated summary of the publication An investigation into eye protection for patients receiving oral psoralen photochemotherapy (PUVA) from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This academic article, published in&nbsp;<em>Photochemical &amp; Photobiological Sciences</em>, presents research on&nbsp;the effectiveness of eye protection for patients undergoing oral psoralen photochemotherapy (PUVA), a treatment for skin conditions. The study investigates various types of eyewear, including sunglasses and safety glasses, assessing their ability to&nbsp;block ultraviolet (UV) radiation&nbsp;following psoralen ingestion. While laboratory measurements showed many lenses effectively block UV,&nbsp;real-world simulation experiments revealed that factors beyond the lens, such as frame design and fit, significantly impact overall protection. The findings highlight the importance of choosing eyewear with&nbsp;close-fitting, wrap-around styles and darker frames&nbsp;to minimise UV exposure from various angles, particularly during the period of heightened photosensitivity after taking psoralen.</p><br><p>Publication: https://doi.org/10.1007/s43630-025-00714-x</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is an AI generated summary of the publication An investigation into eye protection for patients receiving oral psoralen photochemotherapy (PUVA) from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This academic article, published in&nbsp;<em>Photochemical &amp; Photobiological Sciences</em>, presents research on&nbsp;the effectiveness of eye protection for patients undergoing oral psoralen photochemotherapy (PUVA), a treatment for skin conditions. The study investigates various types of eyewear, including sunglasses and safety glasses, assessing their ability to&nbsp;block ultraviolet (UV) radiation&nbsp;following psoralen ingestion. While laboratory measurements showed many lenses effectively block UV,&nbsp;real-world simulation experiments revealed that factors beyond the lens, such as frame design and fit, significantly impact overall protection. The findings highlight the importance of choosing eyewear with&nbsp;close-fitting, wrap-around styles and darker frames&nbsp;to minimise UV exposure from various angles, particularly during the period of heightened photosensitivity after taking psoralen.</p><br><p>Publication: https://doi.org/10.1007/s43630-025-00714-x</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[COVID-19's Impact on Scottish UV Phototherapy]]></title>
			<itunes:title><![CDATA[COVID-19's Impact on Scottish UV Phototherapy]]></itunes:title>
			<pubDate>Wed, 12 Feb 2025 07:00:00 GMT</pubDate>
			<itunes:duration>15:44</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/67a14aab95d7c2516adc1435/media.mp3" length="45313964" type="audio/mpeg"/>
			<guid isPermaLink="false">67a14aab95d7c2516adc1435</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/photobiology-eh-aye/episodes/67a14aab95d7c2516adc1435</link>
			<acast:episodeId>67a14aab95d7c2516adc1435</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ2KmmM3kQdPGUvQmeBLP/peLaPnvVvwhNHSNTBZ8zsd0fzV2GUZCjc7yljxvaO+jTDC2KkSTnd4owiWSNx4cpQV]]></acast:settings>
			<itunes:subtitle><![CDATA[An AI generated overview of COVID-19's Impact on Scottish UV Phototherapy]]></itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>3</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[<p><br></p><p>This is an AI generated summary of the publication COVID-19's Impact on Scottish UV Phototherapy from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This letter to the editor, published in <em>Clinical and Experimental Dermatology</em>, examines the long-term effects of the COVID-19 pandemic on ultraviolet (UV) phototherapy services in Scotland. Ewan Eadie uses data from Photonet, a Scottish UV phototherapy network, to demonstrate a <strong>26% reduction in patients treated</strong> compared to pre-pandemic levels. He attributes this decrease to a complex interplay of factors including staff shortages, reduced clinic hours, longer waiting lists, and changes in patient preferences and treatment options. Despite this decline, <strong>the author highlights the cost-effectiveness of UV phototherapy</strong> and advocates for service improvements to increase access. The letter concludes by suggesting that many UK dermatology services likely face similar challenges.</p><br><p>Publication: https://doi.org/10.1093/ced/llaf063</p><p>More info on Photonet: https://www.nn.nhs.scot/photonet/</p><p>More info on Phototherapy: https://www.bad.org.uk/pils/phototherapy-nb-uvb/ and https://www.bad.org.uk/pils/phototherapy-topical-puva/ and https://www.bad.org.uk/pils/phototherapy-uva1/</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p><br></p><p>This is an AI generated summary of the publication COVID-19's Impact on Scottish UV Phototherapy from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This letter to the editor, published in <em>Clinical and Experimental Dermatology</em>, examines the long-term effects of the COVID-19 pandemic on ultraviolet (UV) phototherapy services in Scotland. Ewan Eadie uses data from Photonet, a Scottish UV phototherapy network, to demonstrate a <strong>26% reduction in patients treated</strong> compared to pre-pandemic levels. He attributes this decrease to a complex interplay of factors including staff shortages, reduced clinic hours, longer waiting lists, and changes in patient preferences and treatment options. Despite this decline, <strong>the author highlights the cost-effectiveness of UV phototherapy</strong> and advocates for service improvements to increase access. The letter concludes by suggesting that many UK dermatology services likely face similar challenges.</p><br><p>Publication: https://doi.org/10.1093/ced/llaf063</p><p>More info on Photonet: https://www.nn.nhs.scot/photonet/</p><p>More info on Phototherapy: https://www.bad.org.uk/pils/phototherapy-nb-uvb/ and https://www.bad.org.uk/pils/phototherapy-topical-puva/ and https://www.bad.org.uk/pils/phototherapy-uva1/</p><p>More info on the Photobiology Unit: https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Monte Carlo Simulation of Photodynamic Therapy for Glioblastoma</title>
			<itunes:title>Monte Carlo Simulation of Photodynamic Therapy for Glioblastoma</itunes:title>
			<pubDate>Tue, 04 Feb 2025 16:49:36 GMT</pubDate>
			<itunes:duration>13:48</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/67a245219a67c6bc4ec9a940/media.mp3" length="39767084" type="audio/mpeg"/>
			<guid isPermaLink="false">67a245219a67c6bc4ec9a940</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://doi.org/10.1117/1.JBO.29.2.025001</link>
			<acast:episodeId>67a245219a67c6bc4ec9a940</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ08Hkd3ITm4Sbvx5oXLCQAEKiAlroKfr6xPrkRlY4TBT+4EHiGZuYxe05eBT2Hq/JRFrw6G/qMGbR5sdvqsnkmg]]></acast:settings>
			<itunes:subtitle>An overview of the published article Monte Carlo Simulation of Photodynamic Therapy for Glioblastoma</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>2</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[<p>This is an AI generated summary of the publication Monte Carlo Simulation of Photodynamic Therapy for Glioblastoma from the Photobiology Unit, NHS Tayside, University of Dundee and the University of St Andrews.</p><p>Publication: https://doi.org/10.1117/1.JBO.29.2.025001</p><p>More info on Glioblastoma https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-of-brain-tumour-adult/glioblastoma/ </p><p>More info on the INDYGO trial: https://www.oncothai.fr/clinical-trial/336-indygo and https://doi.org/10.1007/s11060-024-04693-4</p><p>The Photobiology Unit at Ninewells Hospital in Dundee https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is an AI generated summary of the publication Monte Carlo Simulation of Photodynamic Therapy for Glioblastoma from the Photobiology Unit, NHS Tayside, University of Dundee and the University of St Andrews.</p><p>Publication: https://doi.org/10.1117/1.JBO.29.2.025001</p><p>More info on Glioblastoma https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-of-brain-tumour-adult/glioblastoma/ </p><p>More info on the INDYGO trial: https://www.oncothai.fr/clinical-trial/336-indygo and https://doi.org/10.1007/s11060-024-04693-4</p><p>The Photobiology Unit at Ninewells Hospital in Dundee https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Daylight Photodynamic Therapy At Home</title>
			<itunes:title>Daylight Photodynamic Therapy At Home</itunes:title>
			<pubDate>Sun, 02 Feb 2025 15:42:24 GMT</pubDate>
			<itunes:duration>20:48</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/679f7f23e7c33ddc007c7792/e/679f9156b1d5e920958a9c74/media.mp3" length="59929004" type="audio/mpeg"/>
			<guid isPermaLink="false">679f9156b1d5e920958a9c74</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://doi.org/10.3390/jcm13247745</link>
			<acast:episodeId>679f9156b1d5e920958a9c74</acast:episodeId>
			<acast:showId>679f7f23e7c33ddc007c7792</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsjcx20GZrJvRt9N9ChDMsscw2E3GaMMSt6pL0CJpVzJ12eITV18AnhMdz/efekezn7lH73iY8WdUFXaLP9/eb6ai+Qchbe07P1lNdUk342z6529t7bshaRVlgaag9iemQ]]></acast:settings>
			<itunes:subtitle>An overview of the published article Daylight Photodynamic Therapy At Home: A Pilot Study</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>1</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/679f7f23e7c33ddc007c7792/1738511182011-d586a763-b0cc-4ebb-8af3-1d4e073004e8.jpeg"/>
			<description><![CDATA[<p>This is an AI generated summary of the publication Daylight Photodynamic Therapy At Home: A Pilot Study from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This research article details a pilot study evaluating a home-use kit for daylight photodynamic therapy (dPDT) to treat actinic keratoses (AKs). The study assessed the kit's usability and practicality, finding it convenient for patients but highlighting the need for comprehensive training and support. While patient willingness to reuse the kit was high, efficacy varied, suggesting a need for improved patient selection and support. The kit's design incorporates sustainability principles, utilising natural sunlight and recyclable materials to minimise environmental impact and hospital visits. Future research will focus on cost-effectiveness, safety, and broader implementation.</p><br><p>Publication: https://doi.org/10.3390/jcm13247745</p><p>More info on Actinic Keratoses: https://www.bad.org.uk/pils/actinic-keratoses/</p><p>More info on Photodynamic Therapy: https://www.bad.org.uk/pils/photodynamic-therapy/</p><p>The Photobiology Unit at Ninewells Hospital in Dundee https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is an AI generated summary of the publication Daylight Photodynamic Therapy At Home: A Pilot Study from the Photobiology Unit, NHS Tayside and the University of Dundee.</p><br><p>This research article details a pilot study evaluating a home-use kit for daylight photodynamic therapy (dPDT) to treat actinic keratoses (AKs). The study assessed the kit's usability and practicality, finding it convenient for patients but highlighting the need for comprehensive training and support. While patient willingness to reuse the kit was high, efficacy varied, suggesting a need for improved patient selection and support. The kit's design incorporates sustainability principles, utilising natural sunlight and recyclable materials to minimise environmental impact and hospital visits. Future research will focus on cost-effectiveness, safety, and broader implementation.</p><br><p>Publication: https://doi.org/10.3390/jcm13247745</p><p>More info on Actinic Keratoses: https://www.bad.org.uk/pils/actinic-keratoses/</p><p>More info on Photodynamic Therapy: https://www.bad.org.uk/pils/photodynamic-therapy/</p><p>The Photobiology Unit at Ninewells Hospital in Dundee https://www.photobiology.scot.nhs.uk/</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<itunes:category text="Health &amp; Fitness">
			<itunes:category text="Medicine"/>
		</itunes:category>
		<itunes:category text="Science">
			<itunes:category text="Life Sciences"/>
		</itunes:category>
    	<itunes:category text="Technology"/>
    </channel>
</rss>
